Published in Lancet on May 05, 1990
Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection. Surg Endosc (2009) 2.13
Laparoscopic total mesorectal excision: a consecutive series of 100 patients. Ann Surg (2003) 1.82
Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut (2002) 1.81
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59
Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg (1994) 1.25
Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg (2006) 1.24
Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surg Endosc (2005) 1.20
Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol (1995) 1.09
Laparoscopic-assisted versus open surgery for colorectal cancer: short- and long-term outcomes comparison. J Laparoendosc Adv Surg Tech A (2012) 1.01
Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis (2004) 0.99
Long-term Outcomes of Laparoscopic Surgery for Colorectal Cancer. J Korean Soc Coloproctol (2011) 0.97
Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study. World J Surg (2009) 0.93
Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol (2006) 0.93
Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg (2005) 0.90
Does t3 subdivision correlate with nodal or distant metastasis in colorectal cancer? J Korean Soc Coloproctol (2012) 0.90
Proforma-based reporting in rectal cancer. Cancer Imaging (2010) 0.87
Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients. Langenbecks Arch Surg (2006) 0.87
Clinical significance of magnetic resonance imaging findings in rectal cancer. World J Radiol (2011) 0.86
Clinical significance of pT sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis (2009) 0.85
The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol (2008) 0.83
Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging (2013) 0.82
Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections. World J Gastroenterol (2004) 0.82
Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81
Elastic laminal invasion in colon cancer: diagnostic utility and histological features. Front Oncol (2012) 0.80
The number of lymph nodes is correlated with mesorectal morphometry. Surg Radiol Anat (2008) 0.80
Surgical outcome of abdominoperineal resection for low rectal cancer in a Nigerian tertiary institution. World J Surg (2009) 0.79
Sphincter-sparing resection for rectal cancer. Clin Colon Rectal Surg (2007) 0.79
Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy. Exp Ther Med (2012) 0.78
An assessment of the anatomical relationship between the pelvic plexus and the rectal wall to determine the indications for its preservation in surgery for rectal cancer. Surg Today (1997) 0.77
Total mesorectal excision for rectal cancer: the truth lies underneath. World J Surg (2004) 0.77
Local recurrence, distant recurrence and survival of rectal cancer. Ochsner J (2006) 0.76
Mesorectal spread and involvement of lateral resection margin in rectal cancer. Lancet (1990) 0.75
Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer. J Surg Oncol (2013) 0.75
Prognostic relevant factors within pT3 rectal carcinomas: depth of invasion or circumferrential resection margins? Int J Colorectal Dis (2003) 0.75
Breaching the mesorectum. Lancet (1990) 0.75
General surgery. Postgrad Med J (1991) 0.75
Nodal spread and micrometastasis within mesorectum. World J Gastroenterol (2005) 0.75
Comparison of the clinical outcomes of laparoscopic-assisted versus open surgery for colorectal cancer. Oncol Lett (2014) 0.75
MRI and its importance in rectal cancer. Cancer Imaging (2000) 0.75
Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review. World J Clin Oncol (2017) 0.75
Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer. Surg Today (2016) 0.75
Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer. Int J Colorectal Dis (2015) 0.75
A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer (2017) 0.75
Audit: an annual assessment of the work and performance of a surgical firm in a regional teaching hospital. Br Med J (1980) 5.55
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Natural history of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 2.52
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Risk prediction in coronary artery surgery: a comparison of four risk scores. Med J Aust (1997) 2.10
Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer (1985) 2.08
Goblet cell carcinoid of the appendix. Cancer (1974) 1.81
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol (1996) 1.78
The distribution of adhesion molecules in human atherosclerosis. Histopathology (1993) 1.67
Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67
Diagnostic lessons learnt from a series of enterovesical fistulae. Colorectal Dis (2002) 1.65
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Ann Oncol (2005) 1.58
Influence of cholecystectomy on symptoms. Br J Surg (1991) 1.54
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol (1997) 1.54
Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol (1997) 1.53
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol (1994) 1.53
Incidence and significance of argentaffin and paneth cells in some tumours of the large intestine. J Clin Pathol (1967) 1.53
Adult-to-adult living donor liver transplantation for fulminant hepatic failure. Med J Aust (2001) 1.50
Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up. Br J Surg (1996) 1.49
c-erbB-2 expression in benign and malignant breast disease. Br J Cancer (1988) 1.47
Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ (1991) 1.46
Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg (1986) 1.46
Anal fistulas at St Mark's Hospital. Br J Surg (1977) 1.45
Small bowel strictures after blunt abdominal trauma. Br J Surg (1979) 1.44
Mammographic accuracy and patient age: a study of 297 patients undergoing breast biopsy. Clin Radiol (1993) 1.40
Sugammadex: restricted vs unrestricted or selective vs non-selective? Anaesth Intensive Care (2012) 1.39
False-positive cytodiagnosis in fibrosing alveolitis. Acta Cytol (1990) 1.38
An unusual presentation of intestinal duplication with a literature review. Dig Dis Sci (1996) 1.38
The effect of aprotinin on thrombelastography in vitro. Anaesth Intensive Care (1996) 1.38
P values and the probability of being right and wrong. Anaesth Intensive Care (2010) 1.37
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
Features of mammorgraphically negative breast tumours. Br J Surg (1981) 1.29
The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer (1990) 1.28
Large paraffin sections and chemical clearance of axillary tissues as a routine procedure in the pathological examination of the breast. Histopathology (1982) 1.28
Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys (1990) 1.25
Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg (2000) 1.23
The septic complications of sigmoid diverticular disease. Br J Surg (1984) 1.22
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma peritonei. J Clin Pathol (1973) 1.21
Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer. Int J Cancer (1988) 1.19
Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol (1997) 1.15
Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol (1998) 1.14
The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis (1986) 1.14
Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancer. Br J Cancer (2006) 1.13
The complications of synchronous combined excision for adenocarcinoma of the rectum at St Mark's Hospital. Br J Surg (1975) 1.12
Management of severe acute colitis in district hospitals. J R Soc Med (1984) 1.11
Was Young's syndrome caused by exposure to mercury in childhood? BMJ (1994) 1.09
The uptake of laparoscopic colorectal surgery in Great Britain and Ireland: a questionnaire survey of consultant members of the ACPGBI. Colorectal Dis (2009) 1.08
A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res (2000) 1.08
Undifferentiated carcinoma of the large intestine. Histopathology (1977) 1.07
Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology (1990) 1.07
Pelvic nerve plexus trauma at radical hysterectomy and simple hysterectomy: the nerve content of the uterine supporting ligaments. Cancer (2000) 1.05
Primary medical therapy for operable breast cancer. Eur J Cancer Clin Oncol (1989) 1.04
Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. Br J Cancer (1990) 1.04
Anal fistulas in Crohn's disease. Br J Surg (1981) 1.03
Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg (1994) 1.03
A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer (2004) 1.01
Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population. Br J Surg (1993) 1.01
Influence of local recurrence on survival: a controversy reviewed from the perspective of soft tissue sarcoma. Br J Surg (1991) 1.01
Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients. Ann Oncol (1995) 1.00
Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol (2002) 0.99
The role of percutaneous nephrostomy in malignant urinary tract obstruction. Clin Radiol (1993) 0.99
Primary malignant melanoma of the rectum. Histopathology (1993) 0.97
Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. Gut (1996) 0.96
Comparative study of the histopathology of breast cancer in a screened and unscreened population investigated by mammography. Histopathology (1985) 0.96
Sweat-gland tumours: a clinical review of cases in one centre over 20 years. Clin Oncol (R Coll Radiol) (2006) 0.95
Referral guidelines for colorectal cancer: a threat or a challenge? Hosp Med (2000) 0.95
The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol (1997) 0.94
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma. Br J Cancer (1998) 0.94
Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut (1994) 0.94
Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89? Clin Oncol (R Coll Radiol) (1992) 0.94
Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer (1994) 0.93
Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol (1993) 0.91
Invasive breast cancer--the tip of an iceberg. Ann R Coll Surg Engl (1983) 0.91
Nitroglycerine ointment for dopamine induced peripheral digital ischemia. Lancet (1983) 0.91
Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis (1997) 0.90
Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol (1994) 0.90
Combined immunohistochemical and immunofluorescence method to determine the phenotype of proliferating cell populations. J Clin Pathol (1992) 0.90
Primary suture of the perineal wound following rectal excision for inflammatory bowel disease. Br J Surg (1978) 0.90
Computed tomography in the assessment of response to limb compression in unilateral lymphoedema. Clin Radiol (1995) 0.89
Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). Br J Cancer (1995) 0.88
Lymph node metastases in early rectal cancer. Br J Surg (1993) 0.88
A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III. Cytopathology (1998) 0.88
Secondary carcinoma of left atrium simulating myxoma. Br Heart J (1980) 0.88
Pulmonary toxicity of inhaled aerosolized prostacyclin therapy--an observational study. Anaesth Intensive Care (2000) 0.88
The first three years of the Guildford Breast Screening Project. Recent Results Cancer Res (1984) 0.87
Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J Clin Pathol (1995) 0.86
Advanced breast cancer. A randomised trial of epidoxorubicin at two different dosages and two administration systems. Acta Oncol (1989) 0.86
The surgical treatment of intestinal obstruction due to left sided carcinoma of the colon. Ann R Coll Surg Engl (1988) 0.86
Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: validation against ligand-binding assay and clinical relevance in breast cancer. Br J Cancer (1995) 0.85
Stapled anastomoses in colorectal surgery: a prospective study. Eur J Surg (1996) 0.85
The relationship between microcalcification and in situ carcinoma of the breast. Clin Radiol (1978) 0.85
Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance. Br J Cancer (1991) 0.85
Breast cancer, prostaglandins and patient survival. Br J Cancer (1989) 0.84
Donor-acquired small cell lung cancer following pulmonary transplantation. Chest (2001) 0.84
Proceedings: Colon cancer and bacterial metabolism in familial polyposis. Gut (1975) 0.83